The global esoteric testing market was valued at $20,218.60 million in 2020, and is estimated to reach $66,214.79 million by 2030, growing at a CAGR of 12.5% from 2021 to 2030.
Esoteric testing is defined as the analysis of rare molecule by various technologies such as flow cytometry, mass spectrometry, real time polymerase chain reaction, enzyme linked immunosorbent assay, and DNA sequencing. It is performed when there is a need for additional information except data from lab testing to establish a prognosis and supervise therapeutic treatment. It requires skilled personnel to conduct test and analyze the result by using various chemical agents and sophisticated instruments. It offers accurate diagnosis of disease and treats disease to deliver quality health care for the individual.
The global esoteric testing market is majorly driven by an alarming increase in the prevalence of infectious and chronic diseases, such as cancer, diabetes, cardiovascular disease, HIV, malaria, and hypertension, rise in government initiative for diagnostic testing, surge in demand for ELISA and RT-PCR test, advancement in R&D activities for drug development, and rise in adoption of early diagnosis testing. For instance, according to the World Health Organization (WHO), in 2020, approximately 10 million deaths were reported due to various types of cancer. As per the same source, in 2019, 1.5 million deaths were reported due to diabetics. Moreover, in February 2021, SRL Diagnostic collaborated with Mayo Clinic laboratories to conduct training, seminars, and conferences to enhance knowledge on esoteric tests in India. Furthermore, in June 2021, J Mitra and Company launched COVID-19 Ag Microlisa Elisa Test Kit, which is designed for in-vitro qualitative detection of COVID-19 antigen in oropharyngeal swabs and nasal sample. It provides better time efficiency by decreasing the turnaround time and provides results within two hours. Thus, increase in demand for ELISA and rise in prevalence of cancer and diabetics are expected to propel the growth of the market.
Increase in the number of diagnostic testing and surge in demand for personalized medicine are the major factors that drive the global esoteric testing market. Moreover, increase in prevalence of genetic disease significantly contributes toward the market growth, owing to the fact that esoteric testing, such as genetic testing, is used for monitoring vital signs for early diagnosis and proper treatment of patients. Rise in demand for early diagnosis of disease for effective treatment acts a key driving force of the global market. Furthermore, governments are taking multiple initiatives to develop a diagnostic testing service, which is expected to boost the market growth. Moreover, in 2019, Thermo Fisher Scientific, Inc., the world leader in service science, introduced the novel generation of mass spectrometry instruments used for diagnosis of diseases. On the contrary, advancements in technology in esoteric testing in emerging nations are anticipated to provide lucrative opportunities for the market expansion. For instance, in 2019, Becton, Dickinson and Company, a leading global medical technology company, launched BD FACSDuet automated flow cytometry system, which enables the clinician laboratories to enhance the efficiency by decreasing error and limiting the manual user interaction.
On the contrary, the high cost associated with esoteric testing and lack of skilled laboratory technicians are anticipated to hinder the market growth during the forecast period. Rise in number of diagnostic testing, advancement of esoteric DNA sequencing technologies in precise medicine, and increase in awareness among the population for early diagnosis lead to the enhancement of the esoteric testing sector. This encourages many key players to enter emerging markets, thus offering a lucrative growth opportunity in the esoteric testing market.
The global esoteric testing market is segmented into type, technology, end user, and region. By type, the market is categorized into infectious disease testing, oncology testing, endocrinology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing.
Some of the major companies that operate in the global esoteric testing market are ARUP Laboratories, Baylor Esoteric and Molecular Laboratory, Foundation Medicine, Healius Limited, Laboratory Corporation, Mayo Foundation for Medical Education and Research, OPKO Health, Quest Diagnostics, Sonic Healthcare Limited, and Stanford Clinical Pathology.
Esoteric testing is defined as the analysis of rare molecule by various technologies such as flow cytometry, mass spectrometry, real time polymerase chain reaction, enzyme linked immunosorbent assay, and DNA sequencing. It is performed when there is a need for additional information except data from lab testing to establish a prognosis and supervise therapeutic treatment. It requires skilled personnel to conduct test and analyze the result by using various chemical agents and sophisticated instruments. It offers accurate diagnosis of disease and treats disease to deliver quality health care for the individual.
The global esoteric testing market is majorly driven by an alarming increase in the prevalence of infectious and chronic diseases, such as cancer, diabetes, cardiovascular disease, HIV, malaria, and hypertension, rise in government initiative for diagnostic testing, surge in demand for ELISA and RT-PCR test, advancement in R&D activities for drug development, and rise in adoption of early diagnosis testing. For instance, according to the World Health Organization (WHO), in 2020, approximately 10 million deaths were reported due to various types of cancer. As per the same source, in 2019, 1.5 million deaths were reported due to diabetics. Moreover, in February 2021, SRL Diagnostic collaborated with Mayo Clinic laboratories to conduct training, seminars, and conferences to enhance knowledge on esoteric tests in India. Furthermore, in June 2021, J Mitra and Company launched COVID-19 Ag Microlisa Elisa Test Kit, which is designed for in-vitro qualitative detection of COVID-19 antigen in oropharyngeal swabs and nasal sample. It provides better time efficiency by decreasing the turnaround time and provides results within two hours. Thus, increase in demand for ELISA and rise in prevalence of cancer and diabetics are expected to propel the growth of the market.
Increase in the number of diagnostic testing and surge in demand for personalized medicine are the major factors that drive the global esoteric testing market. Moreover, increase in prevalence of genetic disease significantly contributes toward the market growth, owing to the fact that esoteric testing, such as genetic testing, is used for monitoring vital signs for early diagnosis and proper treatment of patients. Rise in demand for early diagnosis of disease for effective treatment acts a key driving force of the global market. Furthermore, governments are taking multiple initiatives to develop a diagnostic testing service, which is expected to boost the market growth. Moreover, in 2019, Thermo Fisher Scientific, Inc., the world leader in service science, introduced the novel generation of mass spectrometry instruments used for diagnosis of diseases. On the contrary, advancements in technology in esoteric testing in emerging nations are anticipated to provide lucrative opportunities for the market expansion. For instance, in 2019, Becton, Dickinson and Company, a leading global medical technology company, launched BD FACSDuet automated flow cytometry system, which enables the clinician laboratories to enhance the efficiency by decreasing error and limiting the manual user interaction.
On the contrary, the high cost associated with esoteric testing and lack of skilled laboratory technicians are anticipated to hinder the market growth during the forecast period. Rise in number of diagnostic testing, advancement of esoteric DNA sequencing technologies in precise medicine, and increase in awareness among the population for early diagnosis lead to the enhancement of the esoteric testing sector. This encourages many key players to enter emerging markets, thus offering a lucrative growth opportunity in the esoteric testing market.
The global esoteric testing market is segmented into type, technology, end user, and region. By type, the market is categorized into infectious disease testing, oncology testing, endocrinology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing.
By technology, it is divided into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, mass-spectrometry, real time polymerase chain reaction, DNA sequencing, flow cytometry, and other technologies. By end user, the market is bifurcated into hospital-based laboratories and independent and reference laboratories. On the basis of hospital-based laboratories, the market is further distributed into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, mass-spectrometry, real time polymerase chain reaction, DNA sequencing, flow cytometry, and other technologies. By independent and reference laboratories, the market is further categorized into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, mass-spectrometry, real time polymerase chain reaction, DNA sequencing, flow cytometry, and other technologies. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global esoteric testing market are ARUP Laboratories, Baylor Esoteric and Molecular Laboratory, Foundation Medicine, Healius Limited, Laboratory Corporation, Mayo Foundation for Medical Education and Research, OPKO Health, Quest Diagnostics, Sonic Healthcare Limited, and Stanford Clinical Pathology.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global esoteric testing market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global esoteric testing market.
KEY MARKET SEGMENTS
By Type
- Infectious Disease Testing
- Oncology Testing
- Endocrinology Testing
- Genetic Testing
- Toxicology Testing
- Immunology Testing
- Neurology Testing
- Other Testing
By Technology
- Enzyme-linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Mass Spectrometry
- Real Time Polymerase Chain Reaction
- DNA Sequencing
- Flow Cytometry
- Other Technologies
By End User
- Hospital-based Laboratories
- Enzyme-linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Mass Spectrometry
- Real Time Polymerase Chain Reaction
- DNA Sequencing
- Flow Cytometry
- Other Technologies
- Independent and Reference Laboratories
- Enzyme-linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Mass Spectrometry
- Real Time Polymerase Chain Reaction
- DNA Sequencing
- Flow Cytometry
- Other Technologies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- ARUP Laboratories
- Baylor Esoteric and Molecular Laboratory
- Foundation Medicine
- Healius Limited
- Laboratory Corporation
- Mayo Foundation for Medical Education and Research
- OPKO Health
- Quest Diagnostics
- Sonic Healthcare Limited
- Stanford Clinical Pathology
Frequently Asked Questions about the Global Esoteric Testing Market
What is the estimated value of the Global Esoteric Testing Market?
What is the growth rate of the Global Esoteric Testing Market?
What is the forecasted size of the Global Esoteric Testing Market?
Who are the key companies in the Global Esoteric Testing Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 270 |
| Published | July 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 20218.6 million |
| Forecasted Market Value ( USD | $ 66214.79 million |
| Compound Annual Growth Rate | 12.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Surge in prevalence of chronic, infectious and genetic diseases
3.5.1.2. Increase in demand for ELISA and RT-PCR test
3.5.1.3. Increasing in number of medical laboratories
3.5.1.4. Growth in awareness among individual regarding early diagnosis detection and personalized medicine
3.5.2. Restraints
3.5.2.1. High cost for esoteric testing
3.5.2.2. Lack of skilled professionals & laboratory technicians
3.5.3. Opportunity
3.5.3.1. Rise in technological advancement in esoteric testing
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the Esoteric testing market
CHAPTER 4: ESOTERIC TESTING MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Infectious disease testing
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Oncology Testing
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Endocrinology Testing
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Genetic testing
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Toxicology Testing
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Immunology Testing
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Neurology testing
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. Other Testing
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
CHAPTER 5: ESOTERIC TESTING MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Enzyme-linked immunosorbent assay
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Chemiluminescence Immunoassay
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.4. Mass Spectrometry
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
5.5. Real-time polymerase chain reaction
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market analysis, by country
5.6. DNA sequencing
5.6.1. Key market trends, growth factors, and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market analysis, by country
5.7. Flow cytometry
5.7.1. Key market trends, growth factors, and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market analysis, by country
5.8. Other technologies
5.8.1. Key market trends, growth factors, and opportunities
5.8.2. Market size and forecast, by region
5.8.3. Market analysis, by country
CHAPTER 6: ESOTERIC TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital-based laboratories
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Hospital-based laboratories, by technology
6.3. Independent & reference laboratories
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Independent & reference laboratories, by technology
CHAPTER 7: ESOTERIC TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America esoteric testing market, by type
7.2.3. North America esoteric testing market, by technology
7.2.4. North America esoteric testing market, by end user
7.2.5. Market size and forecast, by country
7.2.5.1. U. S.
7.2.5.1.1. U. S. esoteric testing market, by type
7.2.5.1.2. U. S. esoteric testing market, by technology
7.2.5.1.3. U. S. esoteric testing market, by end user
7.2.5.2. Canada
7.2.5.2.1. Canada esoteric testing market, by type
7.2.5.2.2. Canada esoteric testing market, by technology
7.2.5.2.3. Canada esoteric testing market, by end user
7.2.5.3. Mexico
7.2.5.3.1. Mexico esoteric testing market, by type
7.2.5.3.2. Mexico esoteric testing market, by technology
7.2.5.3.3. Mexico esoteric testing market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe esoteric testing market, by type
7.3.3. Europe esoteric testing market, by technology
7.3.4. Europe esoteric testing market, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Germany esoteric testing market, by type
7.3.5.1.2. Germany esoteric testing market, by technology
7.3.5.1.3. Germany esoteric testing market, by end user
7.3.5.2. France
7.3.5.2.1. France esoteric testing market, by type
7.3.5.2.2. France esoteric testing market, by technology
7.3.5.2.3. France esoteric testing market, by end user
7.3.5.3. UK
7.3.5.3.1. UK esoteric testing market, by type
7.3.5.3.2. UK esoteric testing market, by technology
7.3.5.3.3. UK esoteric testing market, by end user
7.3.5.4. Italy
7.3.5.4.1. Italy esoteric testing market, by type
7.3.5.4.2. Italy esoteric testing market, by technology
7.3.5.4.3. Italy esoteric testing market, by end user
7.3.5.5. Spain
7.3.5.5.1. Spain esoteric testing market, by type
7.3.5.5.2. Spain esoteric testing market, by technology
7.3.5.5.3. Spain esoteric testing market, by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe esoteric testing market, by type
7.3.5.6.2. Rest of Europe esoteric testing market, by technology
7.3.5.6.3. Rest of Europe esoteric testing market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific esoteric testing market, by type
7.4.3. Asia-Pacific esoteric testing market, by technology
7.4.4. Asia-Pacific esoteric testing market, by end user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Japan esoteric testing market, by type
7.4.5.1.2. Japan esoteric testing market, by technology
7.4.5.1.3. Japan esoteric testing market, by end user
7.4.5.2. China
7.4.5.2.1. China esoteric testing market, by type
7.4.5.2.2. China esoteric testing market, by technology
7.4.5.2.3. China esoteric testing market, by end user
7.4.5.3. Australia
7.4.5.3.1. Australia esoteric testing market, by type
7.4.5.3.2. Australia esoteric testing market, by technology
7.4.5.3.3. Australia esoteric testing market, by end user
7.4.5.4. India
7.4.5.4.1. India esoteric testing market, by type
7.4.5.4.2. India esoteric testing market, by technology
7.4.5.4.3. India esoteric testing market, by end user
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Rest of Asia-Pacific esoteric testing market, by type
7.4.5.5.2. Rest of Asia-Pacific esoteric testing market, by technology
7.4.5.5.3. Rest of Asia-Pacific esoteric testing market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA esoteric testing market, by type
7.5.3. LAMEA esoteric testing market, by technology
7.5.4. LAMEA esoteric testing market, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Brazil esoteric testing market, by type
7.5.5.1.2. Brazil esoteric testing market, by technology
7.5.5.1.3. Brazil esoteric testing market, by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia esoteric testing market, by type
7.5.5.2.2. Saudi Arabia esoteric testing market, by technology
7.5.5.2.3. Saudi Arabia esoteric testing market, by end user
7.5.5.3. South Africa
7.5.5.3.1. South Africa esoteric testing market, by type
7.5.5.3.2. South Africa esoteric testing market, by technology
7.5.5.3.3. South Africa esoteric testing market, by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA esoteric testing market, by type
7.5.5.4.2. Rest of LAMEA esoteric testing market, by technology
7.5.5.4.3. Rest of LAMEA esoteric testing market, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ARUP Laboratories
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. Baylor Esoteric and Molecular Laboratory
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. Foundation Medicine, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Key strategic moves and developments
8.4. Healius Limited
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Laboratory Corporation
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Mayo Foundation for Medical Education and Research
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. OPKO Health Inc., (OPK)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Quest Diagnostics
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Sonic Healthcare Limited
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Stanford Clinical Pathology
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developmentsLIST OF TABLES
TABLE 01. ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 03. ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 04. ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 05. ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 06. ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 07. ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 08. ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 09. ESOTERIC TESTING MARKET FOR OTHER TESTING, BY REGION, 2020-2030 ($MILLION)
TABLE 10. GLOBAL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 11. ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2020-2030 ($MILLION)
TABLE 12. ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2020-2030 ($MILLION)
TABLE 13. ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY REGION, 2020-2030 ($MILLION)
TABLE 14. ESOTERIC TESTING MARKET FOR REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2020-2030 ($MILLION)
TABLE 15. ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY REGION, 2020-2030 ($MILLION)
TABLE 16. ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY REGION, 2020-2030 ($MILLION)
TABLE 17. ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2020-2030 ($MILLION)
TABLE 18. GLOBAL ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 19. ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2020-2030 ($MILLION)
TABLE 20. HOSPITAL-BASED LABORATORIES, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 21. ESOTERIC TESTING MARKET FOR INDEPENDENT & REFERENCE LABORATORIES, BY REGION, 2020-2030 ($MILLION)
TABLE 22. INDEPENDENT & REFERENCE LABORATORIES, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 23. ESOTERIC TESTING MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 24. NORTH AMERICA ESOTERIC TESTING MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 25. NORTH AMERICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 26. NORTH AMERICA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27. NORTH AMERICA ESOTERIC TESTING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 28. U.S. ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 29. U.S. ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 30. U.S. ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31. CANADA ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 32. CANADA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 33. CANADA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 34. MEXICO ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 35. MEXICO ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 36. MEXICO ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 37. EUROPE ESOTERIC TESTING MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 38. EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 39. EUROPE ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40. EUROPE ESOTERIC TESTING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 41. GERMANY ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 42. GERMANY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 43. GERMANY ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44. FRANCE ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 45. FRANCE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 46. FRANCE ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47. UK ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 48. UK ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 49. UK ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50. ITALY ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 51. ITALY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 52. ITALY ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53. SPAIN ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 54. SPAIN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 55. SPAIN ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 56. REST OF EUROPE ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 57. REST OF EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 58. REST OF EUROPE ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 59. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 60. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 61. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 62. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 63. JAPAN ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 64. JAPAN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 65. JAPAN ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66. CHINA ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 67. CHINA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 68. CHINA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69. AUSTRALIA ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 70. AUSTRALIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 71. AUSTRALIA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72. INDIA ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 73. INDIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 74. INDIA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 76. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 78. LAMEA ESOTERIC TESTING MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 79. LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 80. LAMEA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 81. LAMEA ESOTERIC TESTING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 82. BRAZIL ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 83. BRAZIL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 84. BRAZIL ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 86. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 87. SAUDI ARABIA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 88. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 89. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 90. SOUTH AFRICA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 91. REST OF LAMEA ESOTERIC TESTING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 92. REST OF LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 93. REST OF LAMEA ESOTERIC TESTING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 94. ARUP: COMPANY SNAPSHOT
TABLE 95. ARUP: OPERATING SEGMENTS
TABLE 96. ARUP: PRODUCT PORTFOLIO
TABLE 97. ARUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98. BEM LAB: COMPANY SNAPSHOT
TABLE 99. BEM LAB: OPERATING SEGMENTS
TABLE 100. BEM LAB: PRODUCT PORTFOLIO
TABLE 101. FMI: COMPANY SNAPSHOT
TABLE 102. FMI: OPERATING SEGMENTS
TABLE 103. FMI: PRODUCT PORTFOLIO
TABLE 104. FMI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. HEALIUS: COMPANY SNAPSHOT
TABLE 106. HEALIUS: OPERATING SEGMENTS
TABLE 107. HEALIUS: PRODUCT PORTFOLIO
TABLE 108. HEALIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. LABCORP: COMPANY SNAPSHOT
TABLE 110. LABCORP: OPERATING SEGMENTS
TABLE 111. LABCORP: PRODUCT PORTFOLIO
TABLE 112. LABCORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. MFMER: COMPANY SNAPSHOT
TABLE 114. MFMER: OPERATING SEGMENTS
TABLE 115. MFMER: PRODUCT PORTFOLIO
TABLE 116. OPK: COMPANY SNAPSHOT
TABLE 117. OPK: OPERATING SEGMENTS
TABLE 118. OPK: PRODUCT PORTFOLIO
TABLE 119. OPK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 121. QUEST DIAGNOSTICS: OPERATING SEGMENTS
TABLE 122. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 123. QUEST DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124. SONIC: COMPANY SNAPSHOT
TABLE 125. SONIC: OPERATING SEGMENTS
TABLE 126. SONIC: PRODUCT PORTFOLIO
TABLE 127. SONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128. STANFORD: COMPANY SNAPSHOT
TABLE 129. STANFORD: OPERATING SEGMENTS
TABLE 130. STANFORD: PRODUCT PORTFOLIO
TABLE 131. STANFORD: KEY STRATEGIC MOVES AND DEVELOPMENTSLIST OF FIGURES
FIGURE 01. ESOTERIC TESTING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2020
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2020
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TESTING, BY COUNTRY, 2020-2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2020-2030 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2020-2030 (%)
FIGURE 23. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2020-2030 (%)
FIGURE 24. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR REAL-TIME POLYMERASE CHAIN REACTION, BY COUNTRY, 2020-2030 (%)
FIGURE 25. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY COUNTRY, 2020-2030 (%)
FIGURE 26. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020-2030 (%)
FIGURE 27. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020-2030 (%)
FIGURE 28. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2020-2030 (%)
FIGURE 29. COMPARATIVE ANALYSIS OF ESOTERIC TESTING MARKET FOR INDEPENDENT & REFERENCE LABORATORIES, BY COUNTRY, 2020-2030 (%)
FIGURE 30. HEALIUS: NET SALES, 2018-2020 ($MILLION)
FIGURE 31. HEALIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32. LABCORP: NET SALES, 2018-2020 ($MILLION)
FIGURE 33. LABCORP: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34. LABCORP: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35. MFMER: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. OPK: NET SALES, 2018-2020 ($MILLION)
FIGURE 37. OPK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38. QUEST DIAGNOSTICS: NET SALES, 2018-2020 ($MILLION)
FIGURE 39. QUEST DIAGNOSTICS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40. SONIC: NET SALES, 2018-2020 ($MILLION)
FIGURE 41. SONIC HEALTHCARE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42. SONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43. STANFORD: NET SALES, 2018-2020 ($MILLION)
Companies Mentioned
- ARUP Laboratories
- Baylor Esoteric Molecular Laboratory
- Foundation Medicine
- Healius Limited
- Laboratory Corporation
- Mayo Foundation for Medical Education Research
- OPKO Health
- Quest Diagnostics
- Sonic Healthcare Limited
- Stanford Clinical Pathology.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
